Coombs Test - Indirect
Understanding Coombs Test - Indirect
What is Coombs Test - Indirect?
The Coombs Test - Indirect is a blood test that is used to detect IgG antibodies against red blood cells (RBCs). It is often done during prenatal testing of pregnant women and before a blood transfusion. It assists in identifying blood compatibility problems that could lead to complications like hemolytic disease of the newborn (HDN), transfusion reactions etc., or diagnose autoimmune hemolytic anemia and monitor individuals with autoimmune disorders.
The Coombs Test - Indirect, also known as the indirect antiglobulin test (IAT), looks for antibodies in the blood that may react with RBCs, causing immune-related complications. It helps identify antibodies that are freely floating in the bloodstream, which can potentially bind to RBCs.
The indirect Coombs test is used to screen for blood type compatibility, especially during pregnancy to detect IgG antibodies that are likely to pass on into the fetal blood via placenta leading to hemolytic disease of the newborn(HDN). It checks for Rh incompatibility between the mother and the fetus. Also, it is done in crossmatch screening for blood transfusion to prevent immune reactions and if someone has a blood disorder to identify any harmful antibodies that could be present.
The Coombs Test - Indirect helps identify antibodies early which supports safe blood transfusion practices between the donor and the recipient and pregnancy management, safeguarding both the mother and the baby.
No special preparation is required for this test. However, a duly Filled Coombs (Direct/Indirect) Form is mandatory. Inform your doctor about all the medications or supplements that you may be taking as these could affect the test results, potentially requiring dosage adjustments or temporary discontinuation before the test.
Lab test results may vary across laboratories. Interpretation of the test results requires professional expertise. Therefore, do not self-medicate and always consult your doctor to understand your test results correctly. Narrate your complete medical history to help doctors relate your clinical and laboratory findings.
What is Coombs Test - Indirect used for?
The Coombs Test - Indirect is done:
- To screen for antibodies that may cause hemolytic reactions during blood transfusions.
- To diagnose autoimmune hemolytic anemia.
- To evaluate Rh incompatibility in pregnancy.
- To determine the cause of anemia, jaundice or hemolysis.
- To monitor individuals with a history of hemolytic disease, autoimmune disorders (e.g.,lupus etc.).
What does Coombs Test - Indirect measure?
The Coombs Test - Indirect measures the presence of antibodies in a person's serum that can react with specific antigens on red blood cells. These antibodies are proteins produced by the immune system in response to perceived threats, such as foreign blood group antigens or altered self-antigens in autoimmune conditions. A positive test result suggests the presence of potentially incompatible antibodies, prompting doctors to conduct careful blood type matching before any transfusion.
Furthermore, this test is vital in diagnosing autoimmune hemolytic anemia, where the immune system mistakenly targets the body’s own red blood cells. By revealing the presence of autoantibodies, the Coombs Indirect Test aids in formulating appropriate treatment plans. Overall, the test is essential not only for ensuring safe blood transfusions but also for managing various conditions related to antibody-mediated red blood cell destruction, thus safeguarding individuals' health.
Interpreting Coombs Test - Indirect results
Interpretations
Agglutination: Positive result, antibodies present
No agglutination: Negative result, antibodies absent
Result |
Interpretation |
Negative |
No antibodies detected |
Equivocal |
Positive in undiluted serum up to 1:16 titre |
Positive |
Positive in titre of 1:32 or above Positive in increasing titre in subsequent tests |
Antibodies are produced in the blood upon exposure to incompatible antigens as during a blood transfusion. Antibodies produced in the first incompatible transfusion produce severe reactions upon subsequent transfusions of the same blood type.